Effect of dipyridamole plus aspirin on hemodialysis graft patency. Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR, Martin KJ, McNeil JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI, DAC Study Group (2009) N Engl J Med 360: 2191-201 Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, Himmelfarb J, Vazquez MA, Gassman JJ, Greene T, Radeva MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI, Dialysis Access Consortium Study Group (2008) JAMA 299: 2164-71 Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass. Pretorius M, Murphey LJ, McFarlane JA, Vaughan DE, Brown NJ (2003) Circulation 108: 3079-83 Single versus multiple internal mammary artery grafting for coronary artery bypass: 15-year follow-up of a clinical practice trial. Burfeind WR, Glower DD, Wechsler AS, Tuttle RH, Shaw LK, Harrell FE, Rankin JS (2004) Circulation 110: II27-35 MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia. Evans BC, Hocking KM, Osgood MJ, Voskresensky I, Dmowska J, Kilchrist KV, Brophy CM, Duvall CL (2015) Sci Transl Med 7: 291ra95 Predictive measures of vascular access thrombosis: a prospective study. May RE, Himmelfarb J, Yenicesu M, Knights S, Ikizler TA, Schulman G, Hernanz-Schulman M, Shyr Y, Hakim RM (1997) Kidney Int 52: 1656-62 Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Sreedhara R, Himmelfarb J, Lazarus JM, Hakim RM (1994) Kidney Int 45: 1477-83 Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass. Pretorius M, McFarlane JA, Vaughan DE, Brown NJ, Murphey LJ (2004) Clin Pharmacol Ther 76: 379-87 Vascular access for hemodialysis. Patency rates and results of revision. Palder SB, Kirkman RL, Whittemore AD, Hakim RM, Lazarus JM, Tilney NL (1985) Ann Surg 202: 235-9 Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications. Xue H, Ix JH, Wang W, Brunelli SM, Lazarus M, Hakim R, Lacson E (2013) Am J Kidney Dis 61: 123-30 Use of vascular access blood flow to evaluate vascular access. Hakim RM, Ikizler TA (2001) Am J Kidney Dis 37: 451-2 Intradialytic serial vascular access flow measurements. Rehman SU, Pupim LB, Shyr Y, Hakim R, Ikizler TA (1999) Am J Kidney Dis 34: 471-7 Access survival amongst hemodialysis patients referred for preventive angiography and percutaneous transluminal angioplasty. Chan KE, Pflederer TA, Steele DJ, Lilly MP, Ikizler TA, Maddux FW, Hakim RM (2011) Clin J Am Soc Nephrol 6: 2669-80 Update on post-liver transplantation infections, malignancies, and surgical complications. Washington K (2005) Adv Anat Pathol 12: 221-6 Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. Muto A, Panitch A, Kim N, Park K, Komalavilas P, Brophy CM, Dardik A (2012) Vascul Pharmacol 56: 47-55 Mechanisms of vascular graft thrombosis: role of altered canine platelet sensitivity to thromboxane. McGoff MA, Allen BT, Der T, Sicard GA, Santoro SA (1989) Thromb Res 55: 695-707 Limiting Injury During Saphenous Vein Graft Preparation For Coronary Arterial Bypass Prevents Metabolic Decompensation. Cheung-Flynn J, Song J, Voskresensky I, Wise ES, Liu Y, Xiong Y, Eagle SS, Brophy CM, Flynn CR (2017) Sci Rep 7: 14179 Axillorenal arteriovenous graft: a new approach for dialysis access. Karp SJ, Hawxby A, Burdick JF (2004) J Vasc Surg 40: 379-80 Transduction of peptide analogs of the small heat shock-related protein HSP20 inhibits intimal hyperplasia. Tessier DJ, Komalavilas P, Liu B, Kent CK, Thresher JS, Dreiza CM, Panitch A, Joshi L, Furnish E, Stone W, Fowl R, Brophy CM (2004) J Vasc Surg 40: 106-14 Predictors of major amputation despite patent bypass grafts. Smith AD, Hawkins AT, Schaumeier MJ, de Vos MS, Conte MS, Nguyen LL (2016) J Vasc Surg 63: 1279-88 Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury. Hocking KM, Luo W, Li FD, Komalavilas P, Brophy C, Cheung-Flynn J (2016) J Vasc Surg 64: 210-8 In-center thrombolysis for clotted AV access: a cohort review. Umanath K, Morrison RS, Christopher Wilbeck J, Schulman G, Bream P, Dwyer JP (2013) Semin Dial 26: 124-9 Angioscopic observations after percutaneous thrombectomy of thrombosed hemodialysis grafts. Vesely TM, Hovsepian DM, Darcy MD, Brown DB, Pilgram TK (2000) J Vasc Interv Radiol 11: 971-7 Platelet interactions with the vessel wall and prosthetic grafts. Rubin BG, Santoro SA, Sicard GA (1993) Ann Vasc Surg 7: 200-7 Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure? Osgood MJ, Harrison DG, Sexton KW, Hocking KM, Voskresensky IV, Komalavilas P, Cheung-Flynn J, Guzman RJ, Brophy CM (2012) Ann Vasc Surg 26: 1130-44 Cell-permeant peptide inhibitors of vasospasm and intimal hyperplasia. Osgood MJ, Flynn CR, Komalavilas P, Brophy C (2013) Vascular 21: 46-53
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.